GLENOIDIMPLANTAT

European patent · EP3917457 · In force

Register entry

Publication number
EP3917457
Application number
EP20707961
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 27, 2020
Published
Dec 8, 2021
Granted
Jul 3, 2024
Protection ends at the latest
Jan 26, 2040
Next annual fee due
Jan 31, 2027
IPC classes
A61F 2/30 (2006.01)
A61F 2/40 (2006.01)
Priority
US 201962797866 P 28.01.2019
PCT application
PCT/US2020/015199 27.01.2020
PCT publication
WO2020/159864 06.08.2020
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. May 14, 2025

    Change

    Published in Swissreg on 14.05.2025

  3. Mar 28, 2025

    Change

    Published in Swissreg on 28.03.2025

  4. Sep 4, 2024

    Agent entered

    Representative
    Novagraaf International SA, Chemin de l'Echo 3, 1213 Onex

    Published in Swissreg on 04.09.2024

  5. Jul 3, 2024

    Granted

    Published in Swissreg on 03.07.2024

Parties

Holder

Encore Medical, L.P. (D/B/A DJO Surgical)

9800 Metric Boulevard, Austin, TX 78758, US

Agent

Novagraaf International SA

Chemin de l'Echo 3, 1213 Onex

Inventor

WILLIAMS, Gerald

Villanova, Pennsylvania 19085, US

GUTIERREZ, Sergio

Tampa, Florida 33602, US

FRANKLE, Mark, A.

Tampa, Florida 33602, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.